L-Carnitine

Description

30ml syrup

Each 1ml syrup contains:

L-Carnitine ………………………………… 300 mg

• Primary carnitine deficiency: skeletal and cardiac muscle myopathy,hepatic encephalopathy

• Secondary carnitine deficiency due to genetically determined disorders, acidurias and disorders of beta-oxidation.

• Secondary carnitine deficiency due to acquired conditions :

Haemodialysis and renal Fanconi Syndrome, Anticonvulsants: Sodium valproate, Pivampicilline therapy.

• L- Carnitine has a cardioprotective effect during Antineoplastic therapy.

• Myocardial infarction: L-Carnitine decreases the infarct size.

• Low birth weight infants.

• Full term infants receiving Soya based formula.

• Improve athletic performance in healthy subjects.

• Long standing leg ulcers.

• Idiopathic asthenozoospermia.

• Hemolytic anemia (Thalassaemia & Sickle cell anemia)

There are no reviews yet.

Be the first to review “L-Carnitine”